XML 45 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Financial Statements - Statements of changes in equity - EUR (€)
Total
Capital
Share premium (*)
Equity instruments issued other than capital
Other Equity
Retained earnings
Revaluation reserves
Other reserves
Treasury shares [Member]
Profit or loss attributable to owners of the parent Member
Interim dividends Member
Accumulated other Comprehensive Income [Member]
Non-Controlling interests- Valuation Adjustments
Non-Controlling interests- Rest
Total Member
Balance at beginning at Dec. 31, 2017   € 3,267,000,000 € 23,992,000,000 € 0 € 54,000,000 € 25,474,000,000 € 12,000,000 € (44,000,000) € (96,000,000) € 3,519,000,000 € (1,043,000,000) € (8,792,000,000) € (3,378,000,000) € 10,358,000,000 € 53,323,000,000
Changes in Equity Abstract                              
Adjustments Of Accounting Policies Applications [1]   0 0 0 0 348,000,000 0 30,000,000 0 (5,000,000) (129,000,000) (1,192,000,000) (1,181,000,000) 1,209,000,000 (919,000,000)
TOTAL RECOGNIZED INCOME/EXPENSES € 3,622,000,000 [1] 0 [2] 0 [2] 0 [2] 0 [2] 0 [2] 0 [2] 0 [2] 0 [2] 5,400,000,000 [2] 0 [2] (1,335,000,000) [2] (1,270,000,000) [2] 827,000,000 [2] 3,622,000,000 [2]
Changes in equity                              
Total Changes in Equity [2]   0 0 0 (4,000,000) 240,000,000 (10,000,000) (24,000,000) (199,000,000) (3,514,000,000) 63,000,000 1,096,000,000 540,000,000 (1,341,000,000) (3,152,000,000)
Issue Of Equity [2]   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Issuances of preferred shares [2]   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Issuance of other equity instruments [2]   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Period or maturity of other issued equity instruments [2]   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Conversion of debt on equity [2]   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Common Stock reduction [2]   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividend distribution [2]   0 0 0 0 (996,000,000) 0 0 0 0 (1,109,000,000) 0 0 (378,000,000) (2,483,000,000)
Purchase of treasury shares [2]   0 0 0 0 0 0 0 (1,684,000,000) 0 0 0 0 0 (1,684,000,000)
Sale or cancellation of treasury shares [2]   0 0 0 0 (24,000,000) 0 0 1,484,000,000 0 0 0 0 0 1,460,000,000
Reclassification of financial liabilities to other equity instruments [2]   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Reclassification of other equity instruments to financial liabilities [2]   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Transfers between total equity entries [2]   0 0 0 0 1,278,000,000 (10,000,000) (23,000,000) 0 (3,514,000,000) 1,172,000,000 1,096,000,000 540,000,000 (540,000,000) 0
Increase/Reduction of equity due to business combinations [2]   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Share based payments [2]   0 0 0 (19,000,000) 0 0 0 0 0 0 0 0 0 (19,000,000)
Other increases or (-) decreases in equity [2]   0 0 0 15,000,000 (17,000,000) 0 (1,000,000) 0 0 0 0 0 (423,000,000) (426,000,000)
Balance at the end at Dec. 31, 2018 52,874,000,000 3,267,000,000 [3],[4] 23,992,000,000 [3],[4] 0 [3],[4] 50,000,000 [3],[4] 23,017,000,000 [3],[4] 3,000,000 [3],[4] (57,000,000) [3],[4] (296,000,000) [3],[4] 5,324,000,000 [3],[4] (975,000,000) [3],[4] (7,215,000,000) [3],[4] (3,236,000,000) [3],[4] 9,000,000,000 [3],[4] 52,874,000,000 [3],[4]
Changes in Equity Abstract                              
Adjustments Of Accounting Policies Applications [5]   0 0 0 0 3,045,000,000 0 20,000,000 0 76,000,000 (134,000,000) (3,007,000,000) (2,054,000,000) 2,054,000,000 0
TOTAL RECOGNIZED INCOME/EXPENSES [5] 4,060,000,000 0 0 0 0 0 0 0 0 3,512,000,000 0 (3,000,000) (282,000,000) 833,000,000 4,060,000,000
Changes in equity                              
Total Changes in Equity [5]   0 0 0 6,000,000 3,326,000,000 (3,000,000) (82,000,000) 234,000,000 (5,400,000,000) 25,000,000 0 0 (115,000,000) (2,009,000,000)
Issue Of Equity [5]   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Issuances of preferred shares [5]   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Issuance of other equity instruments [5]   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Period or maturity of other issued equity instruments [5]   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Conversion of debt on equity [5]   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Common Stock reduction [5]   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividend distribution [5]   0 0 0 0 (1,063,000,000) 0 0 0 0 (1,084,000,000) 0 0 (142,000,000) (2,289,000,000)
Purchase of treasury shares [5]   0 0 0 0 0 0 0 (1,088,000,000) 0 0 0 0 0 (1,088,000,000)
Sale or cancellation of treasury shares [5]   0 0 0 0 13,000,000 0 0 1,322,000,000 0 0 0 0 0 1,335,000,000
Reclassification of financial liabilities to other equity instruments [5]   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Reclassification of other equity instruments to financial liabilities [5]   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Transfers between total equity entries [5]   0 0 0 0 4,364,000,000 (3,000,000) (70,000,000) 0 (5,400,000,000) 1,109,000,000 0 0 0 0
Increase/Reduction of equity due to business combinations [5]   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Share based payments [5]   0 0 0 (4,000,000) 0 0 0 0 0 0 0 0 0 (4,000,000)
Other increases or (-) decreases in equity [5]   0 0 0 11,000,000 13,000,000 0 (13,000,000) 0 0 0 0 0 27,000,000 38,000,000
Balance at the end at Dec. 31, 2019 54,925,000,000 3,267,000,000 [1],[6] 23,992,000,000 [1],[6] 0 [1],[6] 56,000,000 [1],[6] 26,402,000,000 [1],[6] 0 [1],[6] (125,000,000) [1],[6] (62,000,000) [1],[6] 3,512,000,000 [1],[6] (1,084,000,000) [1],[6] (7,235,000,000) [1],[6] (3,526,000,000) [1],[6] 9,727,000,000 [1],[6] 54,925,000,000 [1],[6]
Changes in Equity Abstract                              
Adjustments Of Accounting Policies Applications   0 0 0 0 2,985,000,000 0 6,000,000 0 0 0 (2,992,000,000) (2,045,000,000) 2,045,000,000 0
TOTAL RECOGNIZED INCOME/EXPENSES (3,315,000,000) 0 0 0 0 0 0 0 0 1,305,000,000 0 (4,013,000,000) (1,362,000,000) 756,000,000 (3,315,000,000)
Changes in equity                              
Total Changes in Equity   0 0 0 (14,000,000) 1,120,000,000 0 (45,000,000) 16,000,000 (3,512,000,000) 1,084,000,000 (116,000,000) (16,000,000) (107,000,000) (1,590,000,000)
Issue Of Equity   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Issuances of preferred shares   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Issuance of other equity instruments   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Period or maturity of other issued equity instruments   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Conversion of debt on equity   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Common Stock reduction   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividend distribution   0 0 0 0 (1,065,000,000) 0 0 0 0 0 0 0 (124,000,000) (1,190,000,000)
Purchase of treasury shares   0 0 0 0 0 0 0 (807,000,000) 0 0 0 0 0 (807,000,000)
Sale or cancellation of treasury shares   0 0 0 0 0 0 0 823,000,000 0 0 0 0 0 822,000,000
Reclassification of financial liabilities to other equity instruments   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Reclassification of other equity instruments to financial liabilities   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Transfers between total equity entries   0 0 0 0 2,585,000,000 0 (40,000,000) 0 (3,512,000,000) 1,084,000,000 (116,000,000) (16,000,000) 16,000,000 0
Increase/Reduction of equity due to business combinations   0 0 0 0 0 0 0 0 0 0 0 0 0 0
Share based payments   0 0 0 (22,000,000) 0 0 0 0 0 0 0 0 0 (22,000,000)
Other increases or (-) decreases in equity   0 0 0 8,000,000 (399,000,000) 0 (4,000,000) 0 0 0 0 0 1,000,000 (394,000,000)
Balance at the end at Dec. 31, 2020 € 50,020,000,000 € 3,267,000,000 [7] € 23,992,000,000 [7] € 0 [7] € 42,000,000 [7] € 30,508,000,000 [7] € 0 [7] € (164,000,000) [7] € (46,000,000) [7] € 1,305,000,000 [7] € 0 [7] € (14,356,000,000) [7] € (6,949,000,000) [7] € 12,421,000,000 [7] € 50,020,000,000 [7]
[1]

(*) Restated due to the sale of the stake in BBVA USA (see Notes 3 and 21).

[2]

(*) Restated due to the sale of the stake in BBVA USA (see Notes 3 and 21).

[3]

(*) Restated due to the sale of the stake in BBVA USA (see Notes 3 and 21).

[4]

(**) Balances as of December 31, 2017 as originally reported in the consolidated Financial Statements for the year 2017.

[5]

(*) Restated due to the sale of the stake in BBVA USA (see Notes 3 and 21).

[6]

(**) Balances as of December 31, 201 8 as originally reported in the consolidated Financial Statements for the year 2018.

[7]

(*) Balances as of December 31, 201 9 as originally reported in the consolidated Financ ial Statements for the year 2019 .